O processo de herança na família envelhecida

A herança material é um tema fulcral para as pessoas idosas e suas famílias. No entanto, o conhecimento sobre este tema é ainda escasso. Este estudo tem por finalidade explorar o processo de transmissão da herança, analisar os significados e valores das heranças e suas implicações nas relações e bem-estar na velhice. Contempla o enquadramento da herança no ciclo da vida familiar, análise dos perfis de transmissão da herança, organização das relações de entreajuda entre doadores e herdeiros, explorações dos significados e valores dos bens materiais e aprofundamento dos significados e valores emocionais da herança para doadores e herdeiros. Os resultados sugerem que a herança material é um processo normativo no ciclo da vida familiar, constituindo um ponto focal para a reorganização das relações familiares e bem-estar emocional do idoso. O processo é governado por um sistema de significados e valores orientado para a união e lealdade familiar, reciprocidade da ajuda familiar e igualdade (entre irmãos/herdeiros). Este estudo apresenta limitações, sendo relevante melhorar e expandir os resultados através da análise de diferenças, considerando o sexo, classe socioeconómica, contexto de residência e estrutura familiar (nomeadamente, famílias reconstituídas, pessoas solteiras, casais sem filhos), bem como aprofundar a significação dos valores identificados.

Synthesis of new Aβ-ligands useful in diagnosis of Alzheimer's disease

Alzheimer’s disease is a chronic progressive neurodegenerative disease and is the most common form of dementia (estimated 50−60% of all cases), associated with loss of memory (in particular episodic memory), cognitive decline, and behavioural and physical disability, ultimately leading to death. Alzheimer’s disease is a complex disease, mostly occurring sporadically with no apparent inheritance and being the age the main risk factor. The production and accumulation of amyloid-beta peptide in the central nervous system is a key event in the development of Alzheimer’s disease. This project is devoted to the synthesis of amyloid-beta ligands, fluorophores and blood brain barrier-transporters for diagnosis and therapy of Alzheimer’s disease. Different amyloid-beta ligands will be synthesized and their ability to interact with amyloid-beta plaques will be studied with nuclear magnetic resonance techniques and a process of lead optimization will be performed. Many natural and synthetic compounds able to interact as amyloid-beta ligands have been identified. Among them, a set of small molecules in which aromatic moieties seem to play a key role to inhibit amyloid-beta aggregation, in particular heteroaromatic polycyclic compounds such as tetracyclines. Nevertheless tetracyclines suffer from chemical instability, low water solubility and possess, in this contest, undesired anti-bacterial activity. In order to overcome these limitations, one of our goals is to synthesize tetracyclines analogues bearing a polycyclic structure with improved chemical stability and water solubility, possibly lacking antibacterial activity but conserving the ability to interact with amyloid-beta peptides. Known tetracyclines have in common a fourth cycle without an aromatic character and with different functionalisations. We aim to synthesize derivatives in which this cycle is represented by a sugar moiety, thus bearing different derivatisable positions or create derivatives in which we will increase or decrease the number of fused rings. In order to generate a potential drug-tool candidate, these molecules should also possess the correct chemical-physical characteristics. The glycidic moiety, not being directly involved in the binding, it assures further possible derivatizations, such as conjugation to others molecular entities (nanoparticles, polymeric supports, etc.), and functionalization with chemical groups able to modulate the hydro/lipophilicity. In order to be useful such compounds should perform their action within the brain, therefore they have to be able to cross the blood brain barrier, and to be somehow detected for diagnostic purposes.